Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

Conditions:   Anaemia;   Chronic Kidney Disease (CKD)Intervention:   Sponsor:   AmgenActive, not recruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials